Y-Intercept (HK)’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$885K Sell
59,486
-102,390
-63% -$1.1M 0.02% 1096
2026
Q1
$1.37M Buy
+161,876
New +$1.77M 0.03% 901
2025
Q4
Sell
-172,216
Closed -$2.58M 1550
2025
Q3
$2.58M Sell
172,216
-79,666
-32% -$1.16M 0.06% 471
2025
Q2
$3.55M Buy
251,882
+225,036
+838% +$4.01M 0.09% 351
2025
Q1
$645K Buy
26,846
+18,401
+218% +$649K 0.04% 592
2024
Q4
$315K Sell
8,445
-18,344
-68% -$856K 0.02% 918
2024
Q3
$1.34M Buy
+26,789
New +$1.04M 0.08% 326
2024
Q2
Sell
-10,517
Closed -$575K 1405
2024
Q1
$575K Buy
+10,517
New +$521K 0.04% 642
2023
Q3
Sell
-12,007
Closed -$287K 1081
2023
Q2
$287K Buy
+12,007
New +$207K 0.03% 790

Other funds holding BHVN

Y-Intercept (HK)'s BHVN Position: Q2 2026 in Review

Y-Intercept (HK) reduced its Biohaven (BHVN) stake by 63% in Q2 2026, selling an estimated $1.1M and leaving 59,486 shares worth $885K. The position accounts for 0.02% of the portfolio, ranked #1096.

Y-Intercept (HK) first reported a position in BHVN in Q2 2023 and has held it in 9 quarters since. The position peaked at $3.55M in Q2 2025. 38 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • Y-Intercept (HK) held 59,486 shares of Biohaven worth $885K as of Q2 2026.
  • Y-Intercept (HK) sold 102,390 Biohaven shares in Q2 2026, an estimated $1.1M.
  • Biohaven made up 0.02% of Y-Intercept (HK)'s portfolio in Q2 2026, its #1096 holding.
  • Y-Intercept (HK) first reported a position in Biohaven in Q2 2023 and has held it in 9 quarters since.
  • Y-Intercept (HK)'s Biohaven position peaked at $3.55M in Q2 2025.
  • 38 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.